Anthera Pharmaceuticals, Inc. (ANTH) Tops Q4 EPS by 4c
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) reported Q4 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
